首頁 > 市場調查報告書 > 製藥

癌症呼吸器

市場調查報告書

商品編碼

1387369

鼻咽癌市場報告：2030 年趨勢、預測與競爭分析

Nasopharyngeal Cancer Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年11月01日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

鼻咽癌的趨勢和預測

預計2024年至2030年全球鼻咽癌市場將以3.4%的年複合成長率成長。該市場的主要促進因素是鼻咽癌盛行率的增加以及政府對癌症研究和舉措的資助的增加。全球鼻咽癌市場的未來充滿希望，醫院和診所以及門診手術中心市場充滿機會。

鼻咽癌市場洞察

Lucintel 預測，化療預計在預測期內成長最快，因為它被認為是殺死癌細胞的高效治療方法。

由於對其他環境中通常無法獲得的專業設備和專業知識的需求不斷增加，醫院和診所將繼續成為該市場中最大的部分。

由於癌症發生率高以及治療和診斷意識的提高，北美在預測期內仍然是最大的地區。

本報告回答了 11 個關鍵問題：

Q.1. 細分市場中最有前途和高成長的機會是什麼？
Q.2.哪個細分市場將以更快的速度成長？為什麼？
Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
Q.5. 這個市場的商業風險和競爭威脅是什麼？
Q.6.這個市場有哪些新趨勢？為什麼？
Q.7.市場客戶需求有何改變？
Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

成長機會分析
- 全球鼻咽癌治療市場成長機會
- 全球鼻咽癌市場成長機會（依最終用途）
- 全球鼻咽癌市場按地區成長機會
全球鼻咽癌市場新趨勢
戰略分析
- 新產品開發
- 全球鼻咽癌市場的產能擴張
- 全球鼻咽癌收購和合資企業
- 認證和許可

第7章主要企業概況

Biocon
Bristol-Myers Squibb Company
Cyclacel Pharmaceuticals
F. Hoffman-La Roche
Merck & Co
Novartis
Pfizer
Sanofi
Theravectys
Eli Lilly and Company

簡介目錄

Nasopharyngeal Cancer Trends and Forecast

The future of the global nasopharyngeal cancer market looks promising with opportunities in the hospitals and clinic and ambulatory surgery center markets. The global nasopharyngeal cancer market is expected to grow with a CAGR of 3.4% from 2024 to 2030. The major drivers for this market are growing incidence of nasopharyngeal cancer and increasing government funding for cancer research and initiatives.

A more than 150-page report is developed to help in your business decisions.

Nasopharyngeal Cancer by Segment

The study includes a forecast for the global nasopharyngeal cancer by therapy, end use, and region.

Nasopharyngeal Cancer Market by Therapy [Shipment Analysis by Value from 2018 to 2030]:

Chemotherapy
Immunotherapy
Radiation Therapy
Others

Nasopharyngeal Cancer Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

Hospitals and Clinics
Ambulatory Surgery Centers
Others

Nasopharyngeal Cancer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Nasopharyngeal Cancer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nasopharyngeal cancer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nasopharyngeal cancer companies profiled in this report include-

Biocon
Bristol-Myers Squibb Company
Cyclacel Pharmaceuticals
F. Hoffman-La Roche
Merck & Co
Novartis
Pfizer
Sanofi
Theravectys
Eli Lilly and Company

Nasopharyngeal Cancer Market Insights

Lucintel forecasts that chemotherapy is expected to witness highest growth over the forecast period as it is considered as very effective treatment for killing cancer cells.

Within this market, hospitals and clinics will remain the largest segment due to growing need to access to specialized equipment and expertise that is not typically available in other settings.

North America will remain the largest region over the forecast period due to high prevalence of cancer and growing awareness towards treatment and diagnosis in the region.

Features of the Global Nasopharyngeal Cancer Market

Market Size Estimates: Nasopharyngeal cancer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nasopharyngeal cancer market size by therapy, end use, and region in terms of value ($B).

Regional Analysis: Nasopharyngeal cancer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapies, end uses, and regions for the nasopharyngeal cancer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nasopharyngeal cancer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for nasopharyngeal cancer market?

Answer: The global nasopharyngeal cancer market is expected to grow with a CAGR of 3.4% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the nasopharyngeal cancer market?

Answer: The major drivers for this market are growing incidence of nasopharyngeal cancer and increasing government funding for cancer research and initiatives.

Q3. What are the major segments for nasopharyngeal cancer market?

Answer: The future of the nasopharyngeal cancer market looks promising with opportunities in the hospitals and clinic and ambulatory surgery center markets.

Q4. Who are the key nasopharyngeal cancer market companies?

Answer: Some of the key nasopharyngeal cancer companies are as follows:

Biocon
Bristol-Myers Squibb Company
Cyclacel Pharmaceuticals
F. Hoffman-La Roche
Merck & Co
Novartis
Pfizer
Sanofi
Theravectys
Eli Lilly and Company

Q5. Which nasopharyngeal cancer market segment will be the largest in future?

Answer: Lucintel forecasts that chemotherapy is expected to witness highest growth over the forecast period as it is considered as very effective treatment for killing cancer cells.

Q6. In nasopharyngeal cancer market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of cancer and growing awareness towards treatment and diagnosis in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the nasopharyngeal cancer market by therapy (chemotherapy, immunotherapy, radiation therapy, and others), end use (hospitals and clinics, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Nasopharyngeal Cancer Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Nasopharyngeal Cancer Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Nasopharyngeal Cancer Market by Therapy
- 3.3.1: Chemotherapy
- 3.3.2: Immunotherapy
- 3.3.3: Radiation Therapy
- 3.3.4: Others
3.4: Global Nasopharyngeal Cancer Market by End Use
- 3.4.1: Hospitals and Clinics
- 3.4.2: Ambulatory Surgery Centers
- 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Nasopharyngeal Cancer Market by Region
4.2: North American Nasopharyngeal Cancer Market
- 4.2.2: North American Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others
4.3: European Nasopharyngeal Cancer Market
- 4.3.1: European Nasopharyngeal Cancer Market by Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, and Others
- 4.3.2: European Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others
4.4: APAC Nasopharyngeal Cancer Market
- 4.4.1: APAC Nasopharyngeal Cancer Market by Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, and Others
- 4.4.2: APAC Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others
4.5: ROW Nasopharyngeal Cancer Market
- 4.5.1: ROW Nasopharyngeal Cancer Market by Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, and Others
- 4.5.2: ROW Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Nasopharyngeal Cancer Market by Therapy
- 6.1.2: Growth Opportunities for the Global Nasopharyngeal Cancer Market by End Use
- 6.1.3: Growth Opportunities for the Global Nasopharyngeal Cancer Market by Region
6.2: Emerging Trends in the Global Nasopharyngeal Cancer Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Nasopharyngeal Cancer Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nasopharyngeal Cancer Market
- 6.3.4: Certification and Licensing